|
Volumn 56, Issue 4, 2007, Pages 675-676
|
New opportunities in preventative dermatology: How far should we go?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANESTHETIC AGENT;
CYCLOSPORIN;
GABAPENTIN;
LIVE VACCINE;
METHOTREXATE;
PREDNISONE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
VARICELLA ZOSTER VACCINE;
ANTIVIRAL THERAPY;
ARTICLE;
ATOPIC DERMATITIS;
AUTOIMMUNE DISEASE;
BLISTER;
HEALTH CARE PERSONNEL;
HERPES ZOSTER;
MORBIDITY;
POSTHERPETIC NEURALGIA;
PREVENTIVE MEDICINE;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PSORIASIS;
SKIN DISEASE;
VARICELLA ZOSTER VIRUS;
DERMATOLOGY;
FEMALE;
FORECASTING;
HERPES ZOSTER;
HERPES ZOSTER VACCINE;
HUMANS;
MALE;
PRIMARY PREVENTION;
QUALITY OF HEALTH CARE;
SKIN DISEASES;
UNITED STATES;
VACCINATION;
|
EID: 33947242836
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2006.12.010 Document Type: Article |
Times cited : (3)
|
References (9)
|